What Happened?
San Diego, CA-based Autobahn-Therapeutics Appointed Kevin Finney as Chairman and Chief Executive Officer
About the Company
Autobahn Therapeutics is focused on improving life health for people affected by CNS disorders by driving the regenerative power of the human body. Altering the progressive and debilitating course of these conditions by returning the brain to a healthier state will transcend the benefits offered by existing therapies and allow people to live the futures they deserve.
About the Person
Kevin Finney is Chairman and Chief Executive Officer at Autobahn Therapeutics. Previously, Kevin held various senior HR leadership roles in the industry.
Info Source
News
Short Profile